Address: Russia, 123317 Moscow, Presnenskaya nab., 10,Russia
Tel: (+7-495) 5807377
Medtronic, Inc. is a global leader in medical technology, redefining how technology is used in the management of chronic disease.
Our understanding of human physiology yields a range of therapies that are transforming the treatment of chronic conditions for nearly six million patients worldwide each year.
Headquartered in Minneapolis, Minnesota, Medtronic operates regional headquarters in Switzerland and Japan and does business in more than 120 countries. Medtronic stock is traded on the New York Stock Exchange under the ticker symbol MDT.
Medtronic is active partner in the Russia in proliferating the use of the latest in high technology medical equipment and training Russia’s medical specialists:
Products and services
Perhaps best known for our implantable pacemakers and cardioverter defibrillators (ICDs), other high profile
Medtronic products include heart stents, spinal discs, insulin pumps and continuous glucose monitoring
systems, deep brain stimulation, neurostimulation for chronic pain, and remote monitoring and diagnostic
products for chronic disease management.
Medtronic is composed of eight main business units which develop and manufacture devices and therapies to treat more than 30 chronic diseases, including (but not limited to) heart failure, Parkinson’s disease, urinary incontinence, obesity, chronic pain, spinal disorders, and diabetes.